CBLL

Ceribell Stock Analysis

AI Rating

Low
  • Quality5/10
  • Growth 3/10
  • Value 0/10
Ceribell sales and earnings growth
CBLL Growth
Neutral
  • Revenue Y/Y 36.09%
  • EPS Y/Y 56.93%
  • FCF Y/Y -14.27%
Ceribell gross and profit margin trends
CBLL Profitability
Neutral
  • Gross margin 87.90%
  • EPS margin -60.00%
  • ROIC 5Y 0.00%
Ceribell net debt vs free cash flow
CBLL Risk
Great
  • Debt / Equity 0.1
  • Debt / FCF 0.0
  • Interest coverage -27.3

Ceribell stock volatility is higher than the overall market. We give it a Great risk rating.

More Medical Devices stocks ↗